BGB-283

· BeiGene

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BGB-283, covering 2024-10-23 to 2024-12-27. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Safety and Pharmacokinetics of BGB-283 in Patients With Solid Tumors [Phase 1]